In addition to the four cell lines we previously described (MB002, MB004, HD-MB03, and MHHCALL-4)27, we included five additional AML cell lines (MOLM-13, TF-1, HEL, OCI-AML3, and AML193) to cover a broader range of genetic diversity and cancer vulnerabilities. Here, RUNX2 is linked to acute myeloid leukemia.